Related Experiment Videos
The binding and analgesic properties of a sigma opiate, SKF 10,047
The Journal of Pharmacology and Experimental Therapeutics
|October 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Business-centric data solutions for safeguarding animal agriculture in the United States of America.
Revue scientifique et technique (International Office of Epizootics)·2023
Illegal and Therapeutic Drug Concentrations in Hair Segments - A Timetable of Drug Exposure?
Forensic science review·2015
Adverse effects of two nights of sleep restriction on the hypothalamic-pituitary-adrenal axis in healthy men.
The Journal of clinical endocrinology and metabolism·2014
The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Biochemical pharmacology·2007
A novel drug sequestrant-based therapeutic candidate reverses methamphetamine-induced hyperthermia and hypermetabolism and abates multiorgan toxicity in rats.
The Journal of pharmacology and experimental therapeutics·2026
Shiheleucel, an allogeneic natural killer cell product expanded under chemically defined conditions, in combination with rituximab-based chemotherapy in relapsed/refractory diffuse large B-cell lymphoma: An exploratory clinical study.
The Journal of pharmacology and experimental therapeutics·2026
Calpeptin and protein kinase C inhibition suppress exosome-associated inflammatory signaling and epidermal dysregulation in a 3-dimensional psoriatic skin model.
The Journal of pharmacology and experimental therapeutics·2026
Adiponectin in cigarette smoke-induced epithelial-mesenchymal transition.
The Journal of pharmacology and experimental therapeutics·2026
CE9A215 (inotodiol) ameliorates oxazolone-induced atopic dermatitis by targeting mast cells and proinflammatory cytokines.
The Journal of pharmacology and experimental therapeutics·2026
Mitochondrial proteomic signatures of postcardiac arrest brain injury reveal potential therapeutic targets.
The Journal of pharmacology and experimental therapeutics·2026
Acetazolamide use in idiopathic intracranial hypertension: a real-world cohort study of side effects.
Expert review of neurotherapeutics·2026